Logo image of BENF

BENEFICIENT - CLASS A (BENF) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:BENF - US08178Q3092 - Common Stock

9.61 USD
+1.45 (+17.77%)
Last: 12/23/2025, 10:09:51 AM
Fundamental Rating

0

BENF gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 238 industry peers in the Capital Markets industry. BENF may be in some trouble as it scores bad on both profitability and health. BENF has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BENF had negative earnings in the past year.
BENF had a negative operating cash flow in the past year.
In the past 5 years BENF reported 4 times negative net income.
BENF had a negative operating cash flow in each of the past 5 years.
BENF Yearly Net Income VS EBIT VS OCF VS FCFBENF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 -500M -1B -1.5B -2B

1.2 Ratios

With a Return On Assets value of -24.70%, BENF is not doing good in the industry: 86.97% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -24.7%
ROE N/A
ROIC N/A
ROA(3y)-186.26%
ROA(5y)-113.05%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BENF Yearly ROA, ROE, ROICBENF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 500 -500

1.3 Margins

BENF's Operating Margin has declined in the last couple of years.
The Profit Margin and Operating Margin and Gross Margin are not available for BENF so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3Y-16.43%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BENF Yearly Profit, Operating, Gross MarginsBENF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 500 -500 1K 1.5K 2K

More info and screens

0

2. Health

2.1 Basic Checks

The number of shares outstanding for BENF has been increased compared to 1 year ago.
Compared to 5 years ago, BENF has less shares outstanding
Compared to 1 year ago, BENF has a worse debt to assets ratio.
BENF Yearly Shares OutstandingBENF Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
BENF Yearly Total Debt VS Total AssetsBENF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

BENF has an Altman-Z score of -10.50. This is a bad value and indicates that BENF is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -10.50, BENF is not doing good in the industry: 90.76% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -10.5
ROIC/WACCN/A
WACCN/A
BENF Yearly LT Debt VS Equity VS FCFBENF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

A Current Ratio of 0.01 indicates that BENF may have some problems paying its short term obligations.
The Current ratio of BENF (0.01) is worse than 95.80% of its industry peers.
A Quick Ratio of 0.01 indicates that BENF may have some problems paying its short term obligations.
BENF's Quick ratio of 0.01 is on the low side compared to the rest of the industry. BENF is outperformed by 95.80% of its industry peers.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
BENF Yearly Current Assets VS Current LiabilitesBENF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 95.33% over the past year.
Looking at the last year, BENF shows a very negative growth in Revenue. The Revenue has decreased by -21.25% in the last year.
EPS 1Y (TTM)95.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1800%
Revenue 1Y (TTM)-21.25%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-132.27%

3.2 Future

The Earnings Per Share is expected to grow by 34.08% on average over the next years. This is a very strong growth
Based on estimates for the next years, BENF will show a decrease in Revenue. The Revenue will decrease by -6.36% on average per year.
EPS Next Y27.91%
EPS Next 2Y34.08%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-31.95%
Revenue Next 2Y-6.36%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

BENF Yearly Revenue VS EstimatesBENF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 50M -50M 100M -100M
BENF Yearly EPS VS EstimatesBENF Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -0.5 -1 -1.5 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BENF. In the last year negative earnings were reported.
Also next year BENF is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BENF Price Earnings VS Forward Price EarningsBENF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BENF Per share dataBENF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -2 -4 -6 -8

4.3 Compensation for Growth

A more expensive valuation may be justified as BENF's earnings are expected to grow with 34.08% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.08%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BENF!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

BENEFICIENT - CLASS A

NASDAQ:BENF (12/23/2025, 10:09:51 AM)

9.61

+1.45 (+17.77%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-14 2025-11-14/amc
Earnings (Next)02-09 2026-02-09
Inst Owners0.46%
Inst Owner Change0%
Ins Owners0.88%
Ins Owner Change43.84%
Market Cap1.07B
Revenue(TTM)-41.94M
Net Income(TTM)-78.12M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.12
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-146.96%
Min Revenue beat(2)-175.27%
Max Revenue beat(2)-118.65%
Revenue beat(4)0
Avg Revenue beat(4)-159.77%
Min Revenue beat(4)-294.39%
Max Revenue beat(4)-50.76%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)54.55%
EPS NQ rev (3m)-433.33%
EPS NY rev (1m)-14.69%
EPS NY rev (3m)-331.58%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-69.14%
Revenue NY rev (1m)3061.63%
Revenue NY rev (3m)-55.68%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-8.3
EYN/A
EPS(NY)-0.47
Fwd EYN/A
FCF(TTM)-0.4
FCFYN/A
OCF(TTM)-0.4
OCFYN/A
SpS-0.38
BVpS-2.01
TBVpS-2.13
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -24.7%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-186.26%
ROA(5y)-113.05%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-16.43%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover-0.13
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 20.87%
Cap/Sales -0.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z -10.5
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)56.34%
Cap/Depr(5y)134.67%
Cap/Sales(3y)5.87%
Cap/Sales(5y)13.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)95.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1800%
EPS Next Y27.91%
EPS Next 2Y34.08%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-21.25%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-132.27%
Revenue Next Year-31.95%
Revenue Next 2Y-6.36%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y19.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y31.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y29.02%
OCF growth 3YN/A
OCF growth 5YN/A

BENEFICIENT - CLASS A / BENF FAQ

Can you provide the ChartMill fundamental rating for BENEFICIENT - CLASS A?

ChartMill assigns a fundamental rating of 0 / 10 to BENF.


Can you provide the valuation status for BENEFICIENT - CLASS A?

ChartMill assigns a valuation rating of 1 / 10 to BENEFICIENT - CLASS A (BENF). This can be considered as Overvalued.


How profitable is BENEFICIENT - CLASS A (BENF) stock?

BENEFICIENT - CLASS A (BENF) has a profitability rating of 0 / 10.


Can you provide the financial health for BENF stock?

The financial health rating of BENEFICIENT - CLASS A (BENF) is 0 / 10.